Cargando…
Efficacy of Chinese Herbal Medicine Formula in the Treatment of Mild to Moderate Erectile Dysfunction: Study Protocol for a Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
INTRODUCTION: Erectile dysfunction (ED) is a prevalent condition in urology, primarily managed with PDE5 inhibitors (PDE5Is). However, approximately 20% of patients do not experience improvement in overall sexual satisfaction (OS) after taking PDE5Is. Among these, traditional Chinese medicine (TCM)...
Autores principales: | Xu, Run-Nan, Ma, Jian-Xiong, Zhang, Xin, Liao, Ze-Dong, Fu, Yi-Jia, Lv, Bo-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683653/ https://www.ncbi.nlm.nih.gov/pubmed/38034900 http://dx.doi.org/10.2147/IJGM.S436347 |
Ejemplares similares
-
The herbal formula KH-204 is protective against erectile dysfunction by minimizing oxidative stress and improving lipid profiles in a rat model of erectile dysfunction induced by hypercholesterolaemia
por: Jang, Hoon, et al.
Publicado: (2017) -
Alga Ecklonia bicyclis, Tribulus terrestris, and Glucosamine Oligosaccharide Improve Erectile Function, Sexual Quality of Life, and Ejaculation Function in Patients with Moderate Mild-Moderate Erectile Dysfunction: A Prospective, Randomized, Placebo-Controlled, Single-Blinded Study
por: Sansalone, Salvatore, et al.
Publicado: (2014) -
Evaluation of a multi-herb supplement for erectile dysfunction: a randomized double-blind, placebo-controlled study
por: Shah, Gaurang R, et al.
Publicado: (2012) -
Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial
por: Yao, Dan-Ni, et al.
Publicado: (2016) -
Efficacy and safety of an herbal formula (KBMSI-2) in the treatment of erectile dysfunction: A preliminary clinical study
por: Park, Nam Cheol, et al.
Publicado: (2019)